Literature DB >> 36267245

Comparison of Rhinovirus A-, B-, and C-Associated Respiratory Tract Illness Severity Based on the 5'-Untranslated Region Among Children Younger Than 5 Years.

Akiko Sayama1, Michiko Okamoto1, Raita Tamaki1,2,3, Mariko Saito-Obata1, Mayuko Saito1, Taro Kamigaki1, Yusuke Sayama1, Irene Lirio4, Joanna Ina G Manalo4, Veronica L Tallo4, Socorro P Lupisan4, Hitoshi Oshitani1.   

Abstract

Background: Rhinoviruses (RVs) are among the most frequently detected viruses from hospitalized children with severe acute respiratory infections, being classified into RV-A, RV-B, and RV-C (4 clades: C, GAC1, GAC2, and A2). This study aimed to compare the clinical characteristics and respiratory tract illness severity between the RV species and RV-C clades in children in primary care and hospital settings in rural communities in the Philippines.
Methods: Clinical samples and information of children <5 years old in the Philippines were collected from 2014 to 2016. The samples were tested by reverse-transcription polymerase chain reaction (RT-PCR) targeting the 5'-untranslated region. PCR-positive samples were sequenced, and RV species were identified by phylogenetic analysis.
Results: Overall, 3680 respiratory tract illness episodes in 1688 cohort children were documented; 713 of those were RV positive and identified as RV-A (n = 271), RV-B (n = 47), and RV-C (n = 395: C [n = 76], GAG1 [n = 172], GAG2 [n = 8], A2 [n = 138], and unidentified [n = 1]). Severe illnesses, low oxygen saturation, cough, and wheezing were more common in patients with RV-C, especially with GAC1, than in those with RV-A or RV-B. Furthermore, severe illness was significantly more common in RV-C (GAC1)-positive cases than in RV-A-positive cases (odds ratio, 2.61 [95% CI, 1.17-4.13]). Conclusions: Children infected with RV-C had more severe illnesses than children infected with RV-A and RV-B. Moreover, emerging clades of RV-C were associated with increased severity.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  Philippines; children; respiratory tract illness; rhinovirus; severity

Year:  2022        PMID: 36267245      PMCID: PMC9579461          DOI: 10.1093/ofid/ofac387

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   4.423


  23 in total

1.  Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children.

Authors:  Rainbow K Y Mak; Lai Y Tse; Wai Y Lam; Gary W K Wong; Paul K S Chan; Ting F Leung
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

2.  The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969.

Authors:  A S Monto; J J Cavallaro
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

3.  Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children.

Authors:  Susanna K P Lau; Cyril C Y Yip; Hoi-Wah Tsoi; Rodney A Lee; Lok-Yee So; Yu-Lung Lau; Kwok-Hung Chan; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

4.  Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients.

Authors:  A Piralla; F Rovida; G Campanini; V Rognoni; A Marchi; F Locatelli; G Gerna
Journal:  J Clin Virol       Date:  2009-05-26       Impact factor: 3.168

5.  Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.

Authors: 
Journal:  Lancet       Date:  2019-06-27       Impact factor: 202.731

6.  Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study.

Authors:  Bindongo Price Polycarpe Dembele; Taro Kamigaki; Clyde Dapat; Raita Tamaki; Mariko Saito; Mayuko Saito; Michiko Okamoto; Mary Ann U Igoy; Edelwisa Segubre Mercado; Melisa Mondoy; Veronica L Tallo; Socorro P Lupisan; Shinichi Egawa; Hitoshi Oshitani
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

7.  WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.

Authors:  Kayvon Modjarrad; Birgitte Giersing; David C Kaslow; Peter G Smith; Vasee S Moorthy
Journal:  Vaccine       Date:  2015-06-20       Impact factor: 3.641

8.  Genetics, recombination and clinical features of human rhinovirus species C (HRV-C) infections; interactions of HRV-C with other respiratory viruses.

Authors:  Anne Wisdom; Aldona E Kutkowska; E Carol McWilliam Leitch; Eleanor Gaunt; Kate Templeton; Heli Harvala; Peter Simmonds
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

9.  Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C).

Authors:  Peter McErlean; Laura A Shackelton; Emily Andrews; Dale R Webster; Stephen B Lambert; Michael D Nissen; Theo P Sloots; Ian M Mackay
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

10.  Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.

Authors:  Yuki Furuse; Raita Tamaki; Michiko Okamoto; Mariko Saito-Obata; Akira Suzuki; Mayuko Saito; Tadatsugu Imamura; Irona Khandaker; Isolde Dapat; Fumihiko Ueno; Portia Parian Alday; Alvin Gue Tan; Marianette Tawat Inobaya; Edelwisa Segubre-Mercado; Veronica Tallo; Socorro Lupisan; Hitoshi Oshitani
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.